PATENT CLAIM ANALYSIS

Application Number: 16241587
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "407000"]

Abstract:
Methods of inhibiting the growth or metastasis of a cancer in a subject by inhibiting a Ral GTPase in the subject, and small molecule inhibitors of Ral GTPases useful in the methods of the invention. Pharmaceutical compositions containing the compounds of the invention, and methods of using the same.

Claim (Index 18):
The method of  claim 15 , wherein the pharmaceutical composition is administered in conjunction with one or more geranylgeranyltransferase type I (GGTase-I) inhibitors, surgery, chemotherapy, radiation, immunotherapy, or combinations thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.76667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15324629', '14366035', '15142011', '14239177', '14709580']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7919252143762424
- 35 USC 102 Novelty (BERT): 0.6688525751418882
- Combined Prediction Score: 0.779617950452807
- Mean Citation Score: 506.74004
- Max Citation Score: 728.1792
- Similarity Product: 608.3747125350952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test